Literature DB >> 3936791

Methods for estimating the duration of bacterial carriage.

P De Wals, A Bouckaert.   

Abstract

In two cohort studies on asymptomatic pharyngeal carriage of meningococci and of streptococci among schoolchildren, four methods are used to estimate the duration of bacterial carriage. A first estimate of the mean duration is given by the quotient of prevalence by incidence rate. A second method is based on the estimation of the actual length of truncated observations. A third estimate is given by the analysis of carriage survivorship according to a life table. A fourth method is the fitting of a negative exponential model to the carriage survival curve. For meningococci, the estimates of the median duration of carriage range from 7.7 up to 10.2 months, and from 11.1 up to 14.5 months for the mean. For streptococci, the median values vary from 1.9 up to 2.1 months, and from 2.3 up to 4.4 months for the mean duration. The validity and the consistency of the different estimates are discussed.

Mesh:

Year:  1985        PMID: 3936791     DOI: 10.1093/ije/14.4.628

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  8 in total

1.  Sterilizing immunity elicited by Neisseria meningitidis carriage shows broader protection than predicted by serum antibody cross-reactivity in CEACAM1-humanized mice.

Authors:  Kay O Johswich; Shannon E McCaw; Lea Strobel; Matthias Frosch; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  The influence of hitchhiking and deleterious mutation upon asexual mutation rates.

Authors:  Michael E Palmer; Marc Lipsitch
Journal:  Genetics       Date:  2006-02-19       Impact factor: 4.562

3.  The natural history of meningococcal carriage and disease.

Authors:  C L Trotter; N J Gay; W J Edmunds
Journal:  Epidemiol Infect       Date:  2005-10-20       Impact factor: 2.451

4.  Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.

Authors:  Judith E Mueller; Lassana Sangaré; Berthe-Marie Njanpop-Lafourcade; Zekiba Tarnagda; Yves Traoré; Seydou Yaro; Raymond Borrow; Bradford D Gessner; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

5.  Modelled evaluation of multi-component meningococcal vaccine (Bexsero®) for the prevention of invasive meningococcal disease in infants and adolescents in the UK.

Authors:  J Huels; K M Clements; L J McGARRY; G J Hill; J Wassil; S Kessabi
Journal:  Epidemiol Infect       Date:  2013-11-28       Impact factor: 4.434

6.  The impact of aggregating serogroups in dynamic models of Neisseria meningitidis transmission.

Authors:  Keith D Poore; Chris T Bauch
Journal:  BMC Infect Dis       Date:  2015-07-30       Impact factor: 3.090

7.  Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccines.

Authors:  Lorenzo Argante; Michele Tizzoni; Duccio Medini
Journal:  BMC Med       Date:  2016-06-30       Impact factor: 8.775

8.  Transmission Dynamics and Microevolution of Neisseria meningitidis During Carriage and Invasive Disease in High School Students in Georgia and Maryland, 2006-2007.

Authors:  Mustapha M Mustapha; Jane W Marsh; Kathleen A Shutt; Jessica Schlackman; Chinelo Ezeonwuka; Monica M Farley; David S Stephens; Xin Wang; Daria Van Tyne; Lee H Harrison
Journal:  J Infect Dis       Date:  2021-06-15       Impact factor: 5.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.